Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Artemether-Lumefantrine Tab 20-120mg
DRUG
2 trials
Sponsors
Muhimbili University of Health and Allied Sciences
, Didier Menard
Conditions
Artemisinin-resistant
Drug Resistance
Ethiopia
Malaria (Plasmodium Falciparum)
Malaria,Falciparum
Phase 4
Prolonging the Therapeutic Life Span of Artemisinin-based Combination Therapies (ACT) in Bagamoyo District, Tanzania
Completed
NCT03241901
Muhimbili University of Health and Allied Sciences
Malaria,Falciparum
Start: 2017-07-27
End: 2018-02-17
Updated: 2018-03-27
Unknown Phase
Artemisinin Partial Resistance in Ethiopian Plasmodium Falciparum: A Multisite Clinical, Molecular and In Vitro Study
Completed
NCT07527182
Didier Menard
Artemisinin-resistant, Drug Resistance, Ethiopia +1
Start: 2024-05-01
End: 2026-04-07
Updated: 2026-04-14
Related Papers
Clinical, molecular, and in vitro evidence of artemisinin partial resistance in Ethiopian Plasmodium falciparum: a prospective, multisite, surveillance study.
2026-08-04
Electrocardiographic safety evaluation of extended artemether-lumefantrine treatment in patients with uncomplicated Plasmodium falciparum malaria in Bagamoyo District, Tanzania.
2020-07-14
2 citations
Parasite clearance, cure rate, post-treatment prophylaxis and safety of standard 3-day versus an extended 6-day treatment of artemether-lumefantrine and a single low-dose primaquine for uncomplicated Plasmodium falciparum malaria in Bagamoyo district, Tanzania: a randomized controlled trial.
2020-06-23
10 citations